Continued investigation of the molecular interactions between DDT and canonical and non-canonical receptors and effects on downstream signaling may elucidate features that are unique from MIF and provide further insight into the added benefit of a dual-MIF/DDT inhibition approach in cancer treatment using murine models. This evidence concerns the gene MIF and cancer.